TetraLogic Pharmaceuticals Corp

Free In-Depth Equity Research Report

Tetralogic Pharmaceuticals shares gained 13.09 percent to close at $7.69 a share Wednesday. The stock traded between $6.94 and $7.85 on volume of 169,212 shares traded. Analysts at WBB Securities have recently upgraded the company’s rating to “buy” from “speculative buy”. Shares of Tetralogic Pharmaceuticals have fallen approximately 20.0 percent year-to-date. Going forward ... (see research report)
fanned_report

Access Your TetraLogic Pharmaceuticals Corp Report Now!